Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.
JAMA Netw Open. 2024 Oct 1;7(10):e2442324. doi: 10.1001/jamanetworkopen.2024.42324.
Heyde syndrome is the cooccurrence of aortic stenosis and gastrointestinal bleeding secondary to vascular lesions, including angiodysplasias. Several studies have demonstrated cessation of gastrointestinal bleeding after transcatheter aortic valve implantation (TAVI), but the etiology and effects on vascular lesions are largely unknown.
To examine the associations of TAVI with gastrointestinal vascular lesions and identify factors associated with recovery among patients with iron deficiency anemia and severe aortic stenosis.
DESIGN, SETTING, AND PARTICIPANTS: In this prospective, single-center cohort study, patients with iron deficiency anemia on the TAVI waiting list from September 2020 to February 2022 were assessed by capsule endoscopy. Those with vascular lesions were reassessed 6 months after TAVI. Endoscopic images were anonymized and evaluated by 2 independent researchers. Data were analyzed from September 2022 to August 2024.
TAVI.
The primary outcome was the mean difference in the number of vascular lesions before vs after TAVI.
A total of 24 patients (mean [SD] age, 77.4 [7.1] years; 18 [75.0%] male) underwent capsule endoscopy, and vascular lesions were present in 18 patients (75.0%). TAVI was performed in 15 of 18 patients with vascular lesions, of whom 11 agreed to a second capsule endoscopy. The mean (SD) number of vascular lesions across the gastrointestinal tract decreased from 6.4 (5.6) lesions before TAVI to 2.0 (2.1) lesions 6 months after TAVI (P = .04). The number of vascular lesions decreased in 9 of 11 patients (81.8%), including 6 patients (54.5%) who no longer had typical angiodysplasias. Resolution of angiodysplasias was less frequent in patients who had multiple valvular heart disease before TAVI (0 of 3 patients) vs those without multiple valvular heart disease (6 of 8 patients [75.0%]) and in patients with significant paravalvular leakage after TAVI (2 of 5 patients [40.0%]) vs those without significant leakage (4 of 6 patients [66.7%]).
In this cohort study of 24 patients with iron deficiency anemia and severe aortic stenosis, angiodysplasias were present in 75.0% of patients. TAVI was associated with reduced size and number of angiodysplasias in these patients. These findings suggest that TAVI not only improves aortic stenosis but may also reduce gastrointestinal bleeding by resolving vascular lesions, offering a dual benefit for patients with Heyde syndrome.
海迪(Heyde)综合征是指主动脉瓣狭窄与胃肠道出血同时存在,后者继发于包括血管发育不良在内的血管病变。几项研究已经证实,经导管主动脉瓣置换术(TAVI)可停止胃肠道出血,但病因和对血管病变的影响在很大程度上尚不清楚。
研究 TAVI 与胃肠道血管病变的相关性,并确定严重主动脉瓣狭窄伴缺铁性贫血患者中与恢复相关的因素。
设计、地点和参与者:在这项前瞻性、单中心队列研究中,2020 年 9 月至 2022 年 2 月期间,TAVI 候补名单上的缺铁性贫血患者接受胶囊内镜检查。有血管病变的患者在 TAVI 后 6 个月进行重新评估。对匿名内镜图像进行评估,并由 2 位独立研究员进行评估。数据分析于 2022 年 9 月至 2024 年 8 月进行。
TAVI。
主要结局是 TAVI 前后血管病变数量的平均差异。
共 24 例患者(平均[标准差]年龄 77.4[7.1]岁;18 例[75.0%]为男性)接受了胶囊内镜检查,18 例(75.0%)存在血管病变。在 18 例有血管病变的患者中,有 15 例接受了 TAVI,其中 11 例同意进行第二次胶囊内镜检查。整个胃肠道的血管病变数量从 TAVI 前的 6.4(5.6)个病变减少到 TAVI 后 6 个月的 2.0(2.1)个病变(P = .04)。11 例患者中有 9 例(81.8%)的血管病变数量减少,其中 6 例(54.5%)患者不再存在典型的血管发育不良。与无多种瓣膜性心脏病的患者(3 例中 0 例)相比,在 TAVI 前有多种瓣膜性心脏病的患者(3 例中 0 例)和 TAVI 后有明显瓣周漏的患者(5 例中有 2 例[40.0%])中,血管发育不良的缓解率较低)相比,无明显瓣周漏的患者(6 例中有 4 例[66.7%])。
在这项由 24 例严重主动脉瓣狭窄伴缺铁性贫血患者组成的队列研究中,75.0%的患者存在血管发育不良。TAVI 与这些患者的血管发育不良的大小和数量减少有关。这些发现表明,TAVI 不仅改善主动脉瓣狭窄,而且还可能通过解决血管病变来减少胃肠道出血,为海迪综合征患者带来双重益处。